HHS IG: Impacts of Vertical Integration in Medicare Part D on Sponsors' Drug Costs, Pharmacy Reimbursement, and Enrollee Cost Sharing
May 23, 2026
May 23, 2026
WASHINGTON, May 23 (TNSLrpt) -- The Health and Human Services Inspector General issued the following report (No. OEI-BL-24-00240) on May 15, 2026 entitled "Impacts of Vertical Integration in Medicare Part D on Sponsors' Drug Costs, Pharmacy Reimbursement, and Enrollee Cost Sharing" filed under the Centers for Medicare and Medicaid Services:
Here are excerpts:
* * *
Why OIG Did This Review
Stakeholders have raised concerns about t . . .
Here are excerpts:
* * *
Why OIG Did This Review
Stakeholders have raised concerns about t . . .